Nantahala Capital Management, LLC
Position in AVTX — Avalo Therapeutics, Inc.
CIK 1472322
New Canaan, CT
Position in AVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,414,380
+$15,975,830 QoQ
Shares Held
1,862,250
+50.8% QoQ
Ownership
3.47%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#14
of 125 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $618,281,232 across 50 Biotechnology names. AVTX ranks #2 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SVRA |
Savara Inc
|
6,976,810 | $42,977,149 | |
| 2 | AVTX |
Avalo Therapeutics, Inc.
This page
|
1,862,250 | $34,414,380 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $34,171,674 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
5,136,490 | $31,743,508 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
1,797,476 | $25,775,805 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
820,481 | $22,136,577 | |
| 7 | QURE |
uniQure N.V.
|
455,660 | $20,987,699 | |
| 8 | AURA |
Aura Biosciences, Inc.
|
2,951,030 | $20,952,313 |
All Filings in AVTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,414,380 | 1,862,250 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $34,414,380 | 1,862,250 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,438,550 | 1,235,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,427,600 | 1,235,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,696,850 | 1,235,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $15,696,850 | 1,235,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,965,050 | 995,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,209,000 | 900,000 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $197,451 | 556,202 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,415,477 | 808,844 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,724,961 | 540,667 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,818,742 | 547,814 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,355,163 | 6,710,327 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,965,921 | 6,849,547 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,147,985 | 7,145,874 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,156,233 | 6,952,401 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||